Blood cancer patients on Bruton's tyrosine kinase inhibitors should continue at time of COVID-19 vaccination, study says

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.
👉 Full Story

In the Ghetto Repo man Gets Ran Over while trying to Repossess Black woman’s Car!
- Star Trek Actress Calls Out How Poorly The Show Treated Her Character - Chris Snellgrove
- The Complete Guide to AI Data Centers - seo
- What Is the Difference Between MAFLD and MASH? - Suchandrima Bhowmik
- How to pre-order the Nintendo Switch 2 - Anna Washenko
- Election Results – 2 FL Wins, Voter ID Won in WI; WI Supreme Court Seat a Likely Loss
- UK on alert after H5N1 bird flu spills over to sheep in world-first - Beth Mole

Xiaomi 15: Is It Really That Good?
- Unshittification: 3 tech companies that recently made my life… better - Nate Anderson
- PH government assures assistance for detained Filipinos in Qatar - MeighTimbol
- Portland man on a mission to track down who keeps dumping urine in his recycling bin
- The Most Influential Sci-Fi Film Of The '90s Now Streaming For Free - Chris Snellgrove
- Space Force plans to send refueling devices to space to act as gas stations for satellites
- Carneyval Time! Canada Finally Heading Into Elections